Stocks and Investing Stocks and Investing
Tue, October 8, 2019
Mon, October 7, 2019
Fri, October 4, 2019

Matthew Mishan Maintained (ANGO) at Buy with Decreased Target to $21 on, Oct 4th, 2019


Published on 2024-10-26 16:40:27 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "AngioDynamics, Inc." (ANGO) at Buy with Decreased Target from $30 to $21 on, Oct 4th, 2019.

Matthew, nor any peers, have made any analyst calls on ANGO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources